ID
14026
Description
Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS); ODM derived from: https://clinicaltrials.gov/show/NCT02250937
Link
https://clinicaltrials.gov/show/NCT02250937
Keywords
Versions (1)
- 3/22/16 3/22/16 -
Uploaded on
March 22, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myeloid Leukemia NCT02250937
Eligibility Acute Myeloid Leukemia NCT02250937
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Allogeneic or autologous transplantation
Data type
boolean
Alias
- UMLS CUI [1]
- C3899991
Description
Infection
Data type
boolean
Alias
- UMLS CUI [1]
- C3714514
Description
HIV positive
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
Similar models
Eligibility Acute Myeloid Leukemia NCT02250937
- StudyEvent: Eligibility
C3463824 (UMLS CUI [2])
C0398534 (UMLS CUI [2])